Medication Reconciliation in Pulmonary Hypertension

CompletedOBSERVATIONAL
Enrollment

129

Participants

Timeline

Start Date

February 16, 2021

Primary Completion Date

June 15, 2024

Study Completion Date

June 15, 2024

Conditions
Pulmonary HypertensionPulmonary Hypertension Chronic ThromboembolicPulmonary Arterial Hypertension
Interventions
OTHER

Medication reconciliation

MR will be performed directly upon entering the patient's hospital for a first PAH or HTP-Thrombo embolic assessment, just after inclusion. Information regarding the treatments taken by the patient at the time of admission will be retrieved. The entry medication assessment will then be compared with the first medical prescription in order to identify whether medications have been forgotten, prescribed at a different dosage or prescribed when not indicated, etc. All of these differences will be considered medication errors if the reason for the discrepancy is not entered in the patient medical file.

OTHER

Medication reconciliation

After inclusion of the patient, the MR will be carried out retrospectively, that is to say that the information concerning the treatments taken by the patient at the time of the first assessment will be retrieved during the period of the first reassessment (therefore with a delay of 12 months depending on the deadline for the first assessment). All these discrepancies will be considered medication errors if the reason for the discrepancy was not entered in the patient's computerized medical record (IMR).

Trial Locations (1)

94275

Hospital BICETRE, Le Kremlin-Bicêtre

All Listed Sponsors
collaborator

Agence Regionale de Sante d'Ile de France

OTHER_GOV

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT04744584 - Medication Reconciliation in Pulmonary Hypertension | Biotech Hunter | Biotech Hunter